Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol propionate for inflammation after cataract surgery in pediatric population
NCT05724446Phase 3Recruiting
- Sponsor
- Laboratorios Salvat
- Start
- Dec 2022
- Primary completion
- Dec 2025
- Modality
- Nanoparticles, Implantable Devices, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 3 trial of GPN00833 in post-operative inflammation, postoperative pain, sponsored by Laboratorios Salvat. Started Dec 2022; status: recruiting.
02
Drugs
GPN00833
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT05724446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05724446.